Image

The China National COPD Screening Program

Recruiting
35 - 75 years of age
Both
Phase N/A

Powered by AI

Overview

The national COPD screening program is in a cross-sectional manner at the baseline, planning to recruit a total of 800,000 participants from 160 districts or counties (5,000 for each site on average) from 31 provinces, autonomous regions or municipalities directly under the central government of China. The filtered COPD high-risk population and confirmed COPD patients will be managed and followed up according to the standardized clinical guidelines. The major aims of the program are to estimate the prevalences of COPD high-risk population and under- or miss- diagnosed COPD patients, and to manage the development and outcomes of the disease.

Eligibility

Inclusion Criteria:

  • adults aged between 35 and 75 years;
  • residents living in the survey area with more than 6 months in the past year.

Exclusion Criteria:

  • experienced myocardial infarction, stroke or shock in the past 3 months;
  • experienced severe cardiac insufficiency, severe arrhythmia or unstable angina pectoris in the past 4 weeks;
  • experienced massive hemoptysis in the past 4 weeks;
  • received chest, abdominal or ophthalmic surgery in the past 3 months;
  • have mental disorders (e.g. auditory hallucinations, visual hallucinations, taking antipsychotics, seizures requiring medication, etc.);
  • have cognitive impairment (e.g. dementia, comprehension impairment, etc.);
  • have uncontrolled hypertension (i.e. systolic blood pressure > 200 mmHg, diastolic blood pressure > 100 mmHg);
  • present with heart rate >120 beats/min;
  • have aortic aneurysm;
  • have severe hyperthyroidism;
  • are pregnant or lactating women;
  • experienced respiratory infectious diseases (e.g. tuberculosis, influenza, etc.) in the past month.

Study details

Chronic Obstructive Pulmonary Disease

NCT05480176

China-Japan Friendship Hospital

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.